On 8 October 2015, with Gan Weimin of Guangzhou office, Xiao Jiajia and Zhu Yue of Hangzhou office as legal counsel, Hangzhou Meiya Pharmaceutical Co., Ltd. (stock code: 833650; stock short name: Meiya Pharmaceutical) was listed on National Equities Exchange and Quotations.
Meiya Pharmaceutical is a hi-tech biopharmaceutical enterprise specializing in R&D and production of nucleotide, with impressive market presence at home and abroad.